Global Coronary Stents Market (Drug Eluting & Bare Metal) Is Expected To Reach USD 8.3 Billion By 2016

VN:F [1.9.22_1171]
Rating: 5.0/5 (1 vote cast)

Albany NY (March 4, 2013) (CULRAV.ORG) -

According to Transparency Market Research (www.transparencymarketresearch.com) Global Drug Eluting (DES), Bare Metal (BMS) and Other Coronary Stents Market (2011 – 2016)Global Coronary Stents market is estimated to be USD Transparency Market Research6,013million in 2011 and expected to reach USD 8,292million in 2016 at a CAGR of 6.6% over the period 2010 to 2016. The Drug Eluting Stents (DES) segment is the leading market contributor with a share of around 55% – 60% in 2010.

 

Browse full report at http://www.transparencymarketresearch.com/coronary-stents-market.html

 

With the high prevalence of cardiovascular diseases, the global coronary stent market is gaining every year experiencing a 6.6% CAGR growth. Also, owing the growth in demand for minimally invasive procedures, these stents, especially drug eluting stents, are finding rapid increase in their market penetration of more than 60% approximately.

 

The drug eluting stents (DES) segment contributed 55%-60% of the global coronary stent market in 2010. The global DES segment is expected to reach USD 5.3 billion in 2016 after growing at a CAGR of 9.54% from 2011 to 2016.The biggest factor in the growth of this market is found in the aging populations in developed countries. Segmented by geographic regions, the market for Drug Eluting Stents (DES) is growing at 9.0% in the United States, at 3.1% in Europe, at 10% in Asia-Pacific and 3.1% in the rest of the world. At present, the strongest area of growth is drug eluting stents – after the introduction of which the growth in bare-metal stents declined quickly.Increase in the elderly population, lifestyle changes leading to obesity and the advent of advanced technologies such as bio-absorbable and new generation stents are some of the major driving factors for the global coronary stent market.

 

The market for bare-metal stents (BMS) segment globally contributed around 40% to 45% of the global coronary stent market in 2010 and is expected to reach at a market size of USD 2.9 billion by 2016 growing at a rate of 2% CAGR during 2011 and 2016.Increase in the elderly population, lifestyle changes leading to obesity and the advent of advanced technologies such as bio-absorbable and new generation stents are some of the major driving factors for the global coronary stent market.

 

Among the various markets across the globe, the U.S forms the largest market for Coronary stents followed by Europe, the Asia-Pacific region countries, Japan and China.The leading players in this market include Johnson & Johnson, Boston Scientific, Abbott Laboratories and Medtronics making up for the major share of the market worldwide.

 

Scope and Overview

The report covers all the major types of coronary stents – i.e. Drug Eluting Stents, Bare Metal Stents and Bio-Absorbable Stents. The report discusses the key influencing factors for the coronary stent market across the geographies. The report also includes an in-depth analysis of different sub-segments. The report estimates, forecasts the market sizes (2010-2016) and growth rates for different segments and geographies. The report analyses the global trend of coronary stent market and discusses the rationale behind various industry moves. The report provides competitive scenario of this market and highlights major market going-on.An in-depth geographic analysis is conducted for each of the sub-segment in the major regional markets of Americas, Europe, Asia and ROW.The report also covers the strategies followed by “Global Drug Eluting, Bare-Metal and Other Coronary Stents Market” players.

 

Segmentation & Analysis

The report segments and analyzes the “Global Drug Eluting,Bare-Metal and Other Coronary Stents Market” on the basis of following sub-categories:

 

  • Major Geographic Markets
    • North America
    • Europe
    • Asia – Pacific
    • ROW

This section provides in-depth analysis of “Global Drug Eluting, Bare-Metal and Other Coronary Stents Market” that includes market size and growth forecast for each geography and opportunities prevailing in the particular geography.

 

  • Coronary Stents Segments
    • Drug Eluting Stents (DES)
    • Bare-Metal Stents (BMS)
    • Absorbable Stents
    • Bioactive Stents

This section provides in-depth analysis of Coronary Stents market size and growth forecast for each sub segment, driving factors and challenges prevailing in the overall and at the micro market levels, and opportunities and future outlook for all the levels.

 


 

  • Competitive Landscape &Trends analysis

 

This section presents technology-strategy mapping and emerging trends in the coronary .stents market development with analysis of in-market case.

 

  • Product Pipeline Analysis

 

This section analyses the new product developments, clinical trials for coronary stents and their impact on the market.

 

  • Company Profiles of Top Players

 

This section provides brief overview of top market players in the “Global Drug Eluting, Bare-Metal and Other Coronary Stents Market”. The profile of each company includes brief overview, key financials, product & services, recent developments and key strategies adopted by the player.

####

Related Report:

Implantable Drug Delivery Devices (Contraceptives, Drug Infusion Pumps, Intraocular Implants, Drug Eluting, Bio-Absorbable Stents, Biodegradable) Market – Global Industry Analysis, Size, Share, Trends And Forecast, 2012 – 2018 @ http://www.transparencymarketresearch.com/implantable-drug-delivery-devices.html

The global implantable drug delivery devices hold a competitive edge over other drugs and devices owing to the fact that they are implanted at targeted sites and so deliver unaltered amounts of drugs to the affected area. These implantable drug delivery devices are categorized into six product types and this report estimates their market in terms of USD million, for the period 2012 – 2018, keeping 2011 as the base year.

 

About Us

 

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We are privileged with highly experienced team of Analysts, Researchers, and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact

Sheela AK

90 Sate Street, Suite 700

Albany, NY 12207

Tel: +1-518-618-1030

USA – Canada Toll Free: 866-552-3453

Email: sales@transparencymarketresearch.com

Visit: http://www.transparencymarketresearch.com/

VN:F [1.9.22_1171]
Rating: 5.0/5 (1 vote cast)
VN:F [1.9.22_1171]
Rating: 0 (from 2 votes)
Global Coronary Stents Market (Drug Eluting & Bare Metal) Is Expected To Reach USD 8.3 Billion By 2016, 5.0 out of 5 based on 1 rating


Transparency Market Research (TMR) is a market intelligence company providing global business research reports and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers. Author: Transparency Market Research@ Transparency Market Research

Comments are closed.